Study type

Study topic

Disease /health condition
Human medicinal product

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness

Data collection methods

Primary data collection
Non-interventional study

Non-interventional study design

Cross-sectional
Study drug and medical condition

Study drug International non-proprietary name (INN) or common name

CYPROTERONE ACETATE

Medical condition to be studied

Acne
Population studied

Short description of the study population

Physicians who have experience with Diane-35 or its generic versions in five European countries: Austria, the Czech Republic, the Netherlands, Spain, and France.
Physicians who met all of the following eligibility criteria were included:
1. Licensed and practicing dermatologist, gynaecologist, or general practitioner
2. Prescribed Diane-35 or a generic version to at least one patient in the past 6 months

Age groups

Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

759
Study design details

Main study objective

The primary objective of this study is to measure physician knowledge and understanding of the key information contained in the Diane-35 educational material: Patient information card, and Prescribers’ Checklist

Outcomes

The knowledge of the physician concerning Diane-35

Data analysis plan

Analyses will include detailed review of responses to individual questions and potential summary measures across logical groupings of response items. Results will be stratified by country and other logical variables, such as physician specialty and experience with Diane-35 or its generics. A detailed analysis plan describing methods of analysis and presentation and including table shells will be developed prior to starting data collection